Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DHAINASDAQ:PAVMNASDAQ:SSKNOTCMKTS:USAQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.23+2.9%$0.21$0.12▼$3.67$11.06M-0.14390,188 shs237,642 shsPAVMPAVmed$0.65-0.5%$0.71$0.55▼$1.90$11.06M1.11125,714 shs124,510 shsSSKNSTRATA Skin Sciences$2.59+4.9%$2.60$2.10▼$4.30$10.80M0.6813,102 shs52,071 shsUSAQQHSLab$0.26-2.9%$0.21$0.08▼$0.47$2.70M0.6720,986 shs600 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US+2.91%+6.52%+40.72%-52.48%-85.22%PAVMPAVmed-0.49%-0.34%-16.00%-18.31%-64.07%SSKNSTRATA Skin Sciences+1.37%+1.97%-0.38%-3.72%-32.02%USAQQHSLab-2.85%+7.49%+44.48%+5.98%+122.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDHAIDIH Holding USN/AN/AN/AN/AN/AN/AN/AN/APAVMPAVmed3.8291 of 5 stars3.54.00.04.31.90.00.6SSKNSTRATA Skin Sciences2.7635 of 5 stars3.53.00.00.02.21.71.3USAQQHSLab0.4517 of 5 stars0.03.00.00.01.81.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDHAIDIH Holding US 0.00N/AN/AN/APAVMPAVmed 3.00Buy$19.502,914.84% UpsideSSKNSTRATA Skin Sciences 3.00Buy$6.00131.66% UpsideUSAQQHSLab 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest USAQ, PAVM, SSKN, and DHAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025PAVMPAVmedAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $19.502/27/2025SSKNSTRATA Skin SciencesMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$6.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDHAIDIH Holding US$64.47M0.17N/AN/A($0.80) per share-0.29PAVMPAVmed$1.99M5.55N/AN/A($3.35) per share-0.19SSKNSTRATA Skin Sciences$33.62M0.32N/AN/A$3.65 per share0.71USAQQHSLab$1.41M1.92N/AN/A($0.04) per share-6.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDHAIDIH Holding US-$8.44M-$0.30N/A∞N/A-13.59%-5.07%-25.97%N/APAVMPAVmed-$64.18M$0.71N/AN/AN/A602.97%N/A-92.36%8/12/2025 (Estimated)SSKNSTRATA Skin Sciences-$10.83M-$2.27N/AN/AN/A-28.72%-69.33%-17.55%N/AUSAQQHSLab-$470K-$0.04N/A∞N/A-3.24%N/A-3.43%N/ALatest USAQ, PAVM, SSKN, and DHAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025SSKNSTRATA Skin Sciences-$0.56-$0.58-$0.02-$0.58$7.28 million$6.81 million5/14/2025Q1 2025USAQQHSLabN/A-$0.01N/A-$0.01N/A$0.65 million3/28/2025Q4 2024USAQQHSLabN/A-$0.03N/A-$0.03N/A$0.63 million3/27/2025Q4 2024SSKNSTRATA Skin Sciences-$0.40-$1.13-$0.73-$1.13$9.03 million$33.56 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDHAIDIH Holding USN/AN/AN/AN/AN/APAVMPAVmedN/AN/AN/AN/AN/ASSKNSTRATA Skin SciencesN/AN/AN/AN/AN/AUSAQQHSLabN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDHAIDIH Holding USN/A0.510.41PAVMPAVmedN/A0.060.06SSKNSTRATA Skin Sciences1.621.130.94USAQQHSLabN/A0.170.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDHAIDIH Holding US27.76%PAVMPAVmed19.93%SSKNSTRATA Skin Sciences32.43%USAQQHSLabN/AInsider OwnershipCompanyInsider OwnershipDHAIDIH Holding US49.58%PAVMPAVmed7.30%SSKNSTRATA Skin Sciences39.00%USAQQHSLab74.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDHAIDIH Holding USN/A47.34 million20.44 millionN/APAVMPAVmed9017.09 million9.82 millionOptionableSSKNSTRATA Skin Sciences1204.17 million2.54 millionNot OptionableUSAQQHSLab510.59 million2.73 millionNot OptionableUSAQ, PAVM, SSKN, and DHAI HeadlinesRecent News About These CompaniesContrasting InfuSystem (NYSE:INFU) & QHSLab (OTCMKTS:USAQ)May 20, 2025 | americanbankingnews.comQHSLab Enters Advanced Talks for Debt RestructuringMay 16, 2025 | tipranks.comQHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive GrowthMay 16, 2025 | globenewswire.comInvesting in Smarter Healthcare: The New Era of AI-Driven MedicineMay 15, 2025 | theglobeandmail.comQHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025May 15, 2025 | globenewswire.comUSA Equities Engages Hayden IR for Investor RelationsFebruary 26, 2025 | tipranks.comQHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations ProgramFebruary 26, 2025 | globenewswire.comQHSLab’s Record Revenue Growth and First Profitable YearFebruary 18, 2025 | tipranks.comQHSLab, Inc. Reports Record Revenue Growth and Positive Net Income in Preliminary Q4 and FY 2024 Financial ResultsFebruary 18, 2025 | globenewswire.comQHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic GrowthFebruary 11, 2025 | globenewswire.comUSA Equities Highlights 2025 Corporate PresentationJanuary 21, 2025 | tipranks.comUSA Equities to Exhibit at Pri-Med South ConferenceJanuary 16, 2025 | tipranks.comUSA Equities Outlines Growth Strategy Amid ChallengesDecember 17, 2024 | markets.businessinsider.comQHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE TechnologyDecember 13, 2024 | globenewswire.comQHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024November 25, 2024 | globenewswire.comQHSLab, Inc. (OTCQB: USAQ) Reports Record Q3 2024 Revenues, Reflecting Accelerated Expansion in Digital Health and Allergy DiagnosticsNovember 14, 2024 | globenewswire.comUS election latest: Harris set to give first speech since Trump's election winNovember 7, 2024 | news.sky.comThe US city run by Muslim AmericansOctober 26, 2024 | bbc.comUSA Equities Sees Significant Revenue and Profit GrowthOctober 22, 2024 | markets.businessinsider.comQHSLab, Inc. Welcomes Dr. Juan D. Oms, MD, FAPA, as Medical Advisor for Psychiatry and Behavioral HealthOctober 22, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUSAQ, PAVM, SSKN, and DHAI Company DescriptionsDIH Holding US NASDAQ:DHAI$0.23 +0.01 (+2.91%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.23 0.00 (-0.68%) As of 05/23/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.PAVmed NASDAQ:PAVM$0.65 0.00 (-0.49%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.65 +0.00 (+0.03%) As of 05/23/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.STRATA Skin Sciences NASDAQ:SSKN$2.59 +0.12 (+4.86%) Closing price 05/23/2025 03:57 PM EasternExtended Trading$2.58 -0.01 (-0.23%) As of 05/23/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.QHSLab OTCMKTS:USAQ$0.26 -0.01 (-2.85%) As of 05/23/2025 10:55 AM EasternQHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
